Increase expiratory strength with SpiroGym
- Trial ID
- NCT06942533
- Official Title
- The Effect of Visual Feedback From the SpiroGym Mobile Application on Expiratory Muscle Strength Training Performance in Patients With Parkinson's Disease
- Goal
- Increase expiratory strength with SpiroGym
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- General University Hospital, Prague
- Study Type
- INTERVENTIONAL
- Enrollment
- 30 participants
- Conditions
- Parkinson Disease, Breathing Exercises, Telemedicine
- Interventions
- EMST with SpiroGym app, EMST without SpiroGym app
Plain-Language Summary
The goal is to see whether visual feedback from the SpiroGym mobile app helps people with Parkinson's get more out of expiratory muscle strength training, which aims to strengthen the muscles used for coughing and protecting the airway. Participants perform EMST, which makes you exhale against a calibrated resistance to build expiratory muscle power, and the study compares doing EMST with real-time visual cues from the app versus EMST without the app to see if feedback improves technique or performance. The trial is enrolling men and women aged 40 to 80 with Parkinson's who have been on a stable dopaminergic medication dose for at least one month, excluding those with other neurological disorders, major cognitive or psychiatric issues, prior head or neck cancer or surgery, or any acute illness during the study.
Locations
- General University Hospital, Prague, Czechia
- Department of Neurology and Centre of Clinical Neuroscience First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czechia
Frequently Asked Questions
- What is this trial testing?
- This trial is studying EMST with SpiroGym app. The goal is to see whether visual feedback from the SpiroGym mobile app helps people with Parkinson's get more out of expiratory muscle strength training, which aims to strengthen the muscles used for coughing and protecting the airway. Participants perform EMST, which makes you exhale against a calibrated resistance to build expiratory muscle power, and the study compares doing EMST with real-time visual cues from the app versus EMST without the app to see if feedback improves technique or performance. The trial is enrolling men and women aged 40 to 80 with Parkinson's who have been on a stable dopaminergic medication dose for at least one month, excluding those with other neurological disorders, major cognitive or psychiatric issues, prior head or neck cancer or surgery, or any acute illness during the study.
- Who can participate?
- Participants must be between 40 Years and 80 Years.
- Where is this trial located?
- This trial is recruiting at 2 locations.
- Does it cost anything to join?
- No. There is no cost to participate. Study-related care and treatment are provided at no charge.
- How long does the trial last?
- This trial is estimated to last approximately 1 year.